Distribution of Serum Total Homocysteine and Its Association with Diabetes and Cardiovascular Risk Factors of the Insulin Resistance Syndrome in Mexican American Men: The Third National Health and Nutrition Examination Survey

Nutrition Journal

Richard Gillum¹ 

[1] Centers for Disease Control and Prevention, Hyattsville, Maryland, USA

关键词: Obesity.;    diabetes mellitus;    serum;    insulin;    glucose tolerance;    Hispanics;    serum;    Total homocysteine;   

Others  :  1152160
DOI  :  10.1186/1475-2891-2-6

 received in 2003-03-17, accepted in 2003-08-05,  发布年份 2003

【 摘 要 】

Background

Few data have been published on the association of variables of the insulin resistance syndrome and serum total homocysteine (tHcy), a putative risk factor for cardiovascular morbidity, in representative samples of total populations or in Hispanic Americans.

Methods

To describe the distributions of serum tHcy concentration and variables associated with insulin resistance in Mexican American men and to assess their association, data from a cross-sectional survey of a large national sample, the Third National Health and Nutrition Examination Survey were analyzed. Analyses were restricted to Mexican American men aged 40–74 years with data on glycated hemoglobin (%), body mass index (BMI), body fat distribution, HDL cholesterol, fasting serum insulin, serum triglycerides and serum tHcy concentrations.

Results

Cumulative distributions of serum tHcy shifted to the right with increasing age. Log serum tHcy was not associated with prevalence of diagnosed diabetes mellitus or glycated hemoglobin percent or other risk factors other than age. Log serum tHcy concentration showed borderline significant (p = 0.049) positive association with fasting serum insulin concentration independent of age and BMI, only in men aged 60–74.

Conclusion

No consistent association of tHcy with diabetes prevalence or variables of the insulin resistance syndrome were found in Mexican American men aged 40–74 years. Further research is needed on the associations of serum tHcy concentration with insulin resistance and other components of the insulin resistance syndrome in persons of varying ethnicity.

【 授权许可】

   
2003 Gillum; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG: A quantitative assesment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049-1057.
• [2]Hankey GJ, Eikelboom JW: Homocysteine and vascular disease. Lancet 1999, 354:407-413.
• [3]Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S: Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999, 131:363-375.
• [4]Haffner SM: Progress in population analyses of the insulin resistance syndrome. Ann NY Acad Sci 1997, 827:1-12.
• [5]Fagan TC, Deedwania PC: The cardiovascular dysmetabolic syndrome. Am J Med 1998, 105:77S-82S.
• [6]Liese AD, Mayer-Davis EJ, Haffner SM: Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiologic Reviews 1998, 20:157-172.
• [7]Munshi MN, Stone A, Fink I, Fonseca V: Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism 1996, 45:133-135.
• [8]Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 1997, 20:1880-1886.
• [9]Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ: Total homocyst(e)ine concentration and the likelihood of nonfatal stroke. Results from the third National Health and Nutrition Examination Survey, 1988–1994. Stroke 1998, 29:2473-2477.
• [10]Araki A, Sako Y, Ito H: Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis 1993, 103:149-157.
• [11]Chico A, Perez A, Cordoba A, Arcclus R, Carreras G, de Leiva A, Gonzalez-Sastre F, Blanco-Vaca F: Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998, 41:684-693.
• [12]Giltay EJ, Hoogeveen EK, Elbers JMH, Gooren LJG, Asscheman H, Stehouwer CDA: Insulin resistance is associated with elevated plasma total homocysteine levels in health, non-obese subjects. Atherosclerosis 1998, 139:197-198.
• [13]Abbasi F, Facchini F, Humphreys MH, Reaven GM: Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 1999, 146:175-178.
• [14]Bar-On H, Kidron M, Friedlander Y, Ben-Yehuda A, Selhub J, Rosenberg IH, Friedman G: Plasma total homocysteine levels in subjects with hyperinsulinemia. J Intern Med 2000, 247:287-294.
• [15]Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374-381.
• [16]Pawson IG, Martorell R, Mendoza FE: Prevalence of overweight and obesity in US Hispanic populations. Am J Clin Nutr 1991, 1522S-8S.
• [17]Stern MP, Mitchell BD: Diabetes in Hispanic Americans. In In Diabetes in America. 2nd edition. Edited by Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH. Bethesda, Md, National Institutes of Health; 1995:631-659.
• [18]Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner JS: Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: results from the Third National Health and Nutrition Examination Survey. Am Heart J 2000, 139:446-453.
• [19]Morris MS, Jacques PF, Selhub J, Rosenberg IH: Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000, 152:140-148.
• [20]Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. National Center for Health Statistics Vital Health Stat 1994, 1(32):27.
• [21]Vargas CM, Burt Vicki L, Gillum RF: Cardiovascular disease in the NHANES III. Ann Epidemiology 1997, 7:523-525.
• [22]Gunter EW, Lewis BG, Koncikowski SM: Laboratory procedures use for the Third National Health and Nutrition Examination Survey, 1988–94 [CD ROM]. National Center for Health Statistics 1996.
• [23]Wright JW, Bialostosky K, Gunter EW, Carroll MD, Najjar MF, Bowman BA, Johnson CL: Blood folate and vitamin B12: United States, 1988–94. National Center for Health Statistics, Vital Health Stat 1998., 11(243)
• [24]Araki A, Sako Y: Determination of free and total homocysteine in human plasma by HPLC with fluorescence detection. J Chromatogr 1987, 422:43-52.
• [25]Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, Wright JD, Johnson CL: Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999, 69:482-489.
• [26]Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Racial and ethnic differences in glycemic control of adults with Type 2 diabetes. Diabetes Care 1999, 22:403-408.
• [27]Westat Inc: National Health and Nutrition Examination Survey III. Body Measurements (Anthropometry). National Center for Health Statistics. 1996.
• [28]Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998, 22:39-47.
• [29]SAS Institute Inc: SAS Procedures Guide: statistics, version 6 edition. Cary NC: SAS Institute Inc. 1990, 212-55839.
• [30]National Center for Health Statistics, Landis JR, Lepkowski JM, Eklund SA, Stehouwer SA: A statistical methodology for analyzing data from a complex survey, the First National Health and Nutrition Examination Survey. Vital and Health Statistics. Series 2, No.92. DHHS Pub. No. (PHS) 82-1366. Public Health Service. Washington. U.S. Government Printing Office 1982.
• [31]Shah BV, Barnwell BG, Bieler GS: SUDAAN Software for the Statistical Analysis of Correlated Data User's Manual Release 7.0. Research Triangle Park, North Carolina: Research Triangle Institute 1996.
• [32]Finkelstein JD: The regulation of homocysteine metabolism. In In Homocysteine metabolism: from basic science to clinical medicine. Edited by Graham I, Refsum H, Rosenberg IH, Ueland PM, Shuman JM. Boston, Kluwer Academic Publishers; 1997:3-10.
• [33]Hultberg B, Agardh E, Andersson A, Brattstrom L, Isaksson A, Isreaelsson B, Agardh CD: Increased levels of plasma homocysteine associated with nephropathy, but not severe retinopathy in type I diabetes mellitus. Scand J Clin Lab Invest 1991, 51:277-282.
• [34]Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA, Henry RR: Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic by not type 2 diabetic subjects. Metabolism 1998, 47:686-689.
• [35]Anderson RA: Contributing factors to insulin resistance. Role of dietary factors: micronutrients. Nutr Reviews 2000, 58(II):S10-S11.
• [36]Smulders YM, Rakic M, Slaats EH, Treskes M, Sijbrands EJ, Odekerken DA, Stehouwer CD, Silberbussch J: Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease. Diabetes Care 1999, 21:125-132.
• [37]Hanefeld M: The metabolic syndrome: roots, myths, and facts. In In The metabolic syndrome. Edited by Hanefeld M, Leonhardt W. Jena, Gustav Fischer; 1997:13-24.
• [38]Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J: Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999, 100:123-128.
• [39]Flier JS: An overview of insulin resistance. In In Insulin resistance. Edited by Moller DE. Chichester, John Wiley & Sons; 1993:1-8.
• [40]Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL: Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991–1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999, 131:331-339.
• [41]Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland PM, Kvale G: Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 1995, 274:1526-1533.
• [42]Hultberg B, Andersson A, Arnadottir M: Plasma homocysteine in renal failure, diabetes mellitus, and alcoholism. In In Homocysteine metabolism: from basic science to clinical medicine. Edited by Graham I, Refsum H, Rosenberg IH, Ueland PM, Shuman JM. Boston, Kluwer Academic Publishers; 1997:137-144.
• [43]Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJC, Jakobs C, Bouter LM, Heine RJ, Stehouwer CDA: Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998, 18:133-138.
• [44]Laivuori H, Kaaja R, Turpeinen U, Viinikka L, Ylikorkala O: Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 1999, 93:489-493.
• [45]Mohadjer L, Bell B, Waksberg J: National Health and Nutrition Examination Survey III. Accounting for item nonresponse bias. Rockville, MD, WESTAT, Inc 1996.
• [46]Cooper MJ, Zlotkin SH: Day-to-day variation of transferrin receptor and ferritin in healthy men and women. Am J Clin Nutr 1996, 64:738-742.
• [47]Stout RW: Insulin resistance, hyperinsulinemia, dyslipidemia and atherosclerosis. In In Insulin resistance. Edited by Moller DE. Chichester, John Wiley & Sons; 1993:355-384.
• [48]Appel LJ, Miller ER III, Jee SH, Stolzenberg-Solomon R, Lin P, Erlinger T, Nadeau MR, Selhub J: Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation 2000, 102:852-857.
• [49]Janka HU: Metabolic syndrome and type II diabetes. In In The metabolic syndrome. Edited by Hanefeld M, Leonhardt W. Jena, Gustav Fischer; 1997:62-69.
• [50]Docherty K, Steiner DF: Molecular and cellular biology of the beta cell. In In Ellenberg and Rifkin's Diabetes Mellitus. 5th edition. Edited by Porte D Jr, Sherwin RS. Stamford, Connecticut, Appleton Lange; 1997:29-48.
• [51]Reaven GM: The pathophysiological consequences of adipose tissue insulin resistance. In In Insulin resistance: the metabolic syndrome X. Edited by Reaven GM, Laws A. Totowa, New Jersey, Human Press; 1999:233-246.
• [52]Laws A: Insulin resistance and dyslipidemia: implications for coronary heart disease risk. In In Insulin resistance: the metabolic syndrome X. Edited by Reaven GM, Laws A. Totowa, New Jersey, Human Press; 1999:267-280.